Towards Healthcare Research & Consulting

Platelet Rich Plasma Companies and Competitive Landscape

Date : 08 July 2026

Who are the Platelet Rich Plasma Market Top Vendors and What are Their Offerings?

Platelet Rich Plasma Market Companies are Arthrex, Inc., Zimmer Biomet, EmCyte Corporation, Terumo Corporation, Stryker Corporation, Johnson & Johnson, Regen Lab SA

Market Ecosystem Analysis

Ecosystem Segment Key Participants Explanation
Technology Providers EmCyte Corporation, Terumo Blood and Cell Technologies, Regen Lab SA Develop PRP preparation technologies, centrifugation systems, and blood component separation technologies.
Product Manufacturers Zimmer Biomet, Arthrex, Johnson & Johnson (DePuy Synthes), Stryker, Exactech Manufacture PRP preparation kits, biologics systems, orthopedic regenerative products, and surgical solutions.
Service Providers Hospital systems, Sports medicine clinics, Cosmetic surgery clinics, Dental clinics Deliver PRP therapy across multiple specialties.
Platform Providers Arthrex, Zimmer Biomet, EmCyte, Regen Lab Provide integrated PRP preparation platforms and proprietary systems.
CROs/CDMOs NAMSA, Charles River Laboratories Support clinical evaluation and regulatory studies for PRP-related devices and biologics.
Software Vendors Oracle Health, GE HealthCare, Philips Healthcare Clinical workflow, patient management, and imaging systems supporting PRP procedures.
Research Institutions Mayo Clinic, Hospital for Special Surgery, Stanford University, Cleveland Clinic Conduct clinical studies evaluating PRP efficacy across therapeutic applications.
End-User Industries Healthcare, Orthopedics, Sports Medicine, Aesthetic Medicine, Dentistry, Veterinary Medicine Primary commercial users of PRP systems.

Recent Developments in the Platelet Rich Plasma Market

  • In January 2026, a successful acquisition of Platelet-Rich Fibrin Matrix (PRFM) technology was announced by Tiger BioSciences. The system helps in the preparation of high-quality autologous platelet concentrates at the point-of-care setting, supporting the treatment of complex and chronic wounds.
  • In September 2025, the CENTRIO Platelet-Rich-Plasma (PRP) System was launched by Smith+Nephew. The system helps in promoting the natural healing process by maintaining a moist wound environment.

Competitive Landscape

Tier 1
Company Name Headquarters Country Why Relevant to This Market Key Products/Services
Zimmer Biomet Warsaw, Indiana United States Global leader in orthopedic biologics with extensive PRP portfolio GPS® III Platelet Concentrate System, Biologics Portfolio
Arthrex Naples, Florida United States Leading sports medicine and orthopedic biologics company ACP® Double Syringe System, Angel® cPRP System
Terumo Blood and Cell Technologies Lakewood, Colorado United States Global leader in blood component separation technologies SmartPrep®, blood processing technologies
Johnson & Johnson (DePuy Synthes) Raynham, Massachusetts United States Major orthopedic company supporting biologics integration Orthopedic regenerative medicine solutions
Stryker Portage, Michigan United States Strong orthopedic and regenerative medicine presence Orthobiologics portfolio supporting PRP procedures
Tier 2
Company Name Headquarters Country Why Relevant to This Market Key Products/Services
EmCyte Corporation Fort Myers, Florida United States Dedicated PRP technology developer PurePRP®, AbsolutePRP®, platelet concentrate systems
Regen Lab SA Le Mont-sur-Lausanne, Vaud Switzerland Pioneer in PRP tubes and regenerative medicine RegenKit®, cellular therapy systems
Exactech Gainesville, Florida United States Orthopedic company incorporating biologics solutions Biologics solutions for orthopedic surgery
Isto Biologics Hopkinton, Massachusetts United States Regenerative medicine specialist Orthobiologics and PRP-related regenerative products
Cesca Therapeutics Rancho Cordova, California United States Cell processing technologies applicable to PRP preparation Cell processing and regenerative medicine platforms
Tier 3
Company Name Headquarters Country Why Relevant to This Market Key Products/Services
Celling Biosciences Austin, Texas United States Focused exclusively on advanced PRP technologies ART PRP®, cell concentration systems
Dr. PRP USA LLC Weston, Florida United States Specialized PRP preparation systems Dr. PRP Kits, centrifuge systems
Eclipse Aesthetics LLC Dallas, Texas United States Strong presence in aesthetic PRP applications Eclipse PRP®, facial rejuvenation kits
Royal Biologics Hackensack, New Jersey United States Orthobiologics company offering PRP solutions PRP kits and biologic products
ISTO Technologies St. Louis, Missouri United States Regenerative medicine company expanding biologics portfolio Orthobiologic regenerative therapies

Market Growth

The global platelet rich plasma market size is calculated at USD 890.3 million in 2025, driven by a rise in musculoskeletal disorders globally. The market continues to grow USD 1031.15 million in 2026 due to advancements in cosmetic procedures, new PRP product launches, and AI integration. It is expected to reach USD 3866.98 million by 2035 as expanding aesthetic applications, regenerative medicines, and PRP delivery technologies accelerate market expansion registering a CAGR of 15.82% during the period.

Platelet Rich Plasma Market Size is USD 1031.15 Million in 2026.